GLP-1 receptor agonists are reshaping diabetes and obesity care, raising important questions about patient selection, side effect management, long-term outcomes, access, and the evolving role of diabetes care and education specialists (DCESs). In this episode of Diabetes Care Conversations, host Paola Acevedo, PharmD, CDCES, speaks with Diana Isaacs, PharmD, BC-ADM, CDCES, about what DCESs need to know about GLP-1 therapies, including their impact on treatment approaches, the importance of patient education, and emerging opportunities and challenges in care. Listen to more episodes of Diabetes Care Conversations at
https://www.adces.org/practice/the-huddle-podcast
Learn more about ADCES and the many benefits of membership at
adces.org/join.
The Diabetes Care Conversations Podcast is edited by JAG Podcast
Productions: https://jagpodcastproductions.com/
Hosted by Simplecast, an AdsWizz company. See https://pcm.adswizz.com
for information about our collection and use of personal data for
advertising.
